5 August 2024
Chemring Group PLC
Grant of options
Chemring Group PLC ("Chemring" or the "Company") announces that it has today granted, pursuant to The Chemring Group 2018 UK Sharesave Plan, options over 5,983 1p ordinary shares in the capital of the Company to James Mortensen, a director of the Company. The options will be exercisable in three years time at an exercise price of 310p per share.
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
| 1
| Details of the person discharging managerial responsibilities / person closely associated
| |||||
| a)
| Name
|
James Mortensen | ||||
| 2
| Reason for the notification
| |||||
| a)
| Position/status
| Director/PDMR | ||||
| b)
| Initial notification /Amendment
| Initial | ||||
| 3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| |||||
| a)
| Name
| Chemring Group PLC | ||||
| b)
| LEI
| 213800U9A54VQJ5P2J41 | ||||
| 4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| |||||
| a)
| Description of the financial instrument, type of instrument
Identification code
| Options over 1p ordinary shares
GB00B45C9X44 | ||||
| b)
| Nature of the transaction
| Grant of options under The Chemring Group 2018 UK Sharesave Plan | ||||
| c)
| Price(s) and volume(s)
|
| ||||
| d)
| Aggregated information
- Aggregated volume
- Price
| N/A
| ||||
| e)
| Date of the transaction
| 5 August 2024 | ||||
| f)
| Place of the transaction
| Outside a trading venue | ||||
For further information:
| Chemring Group PLC | | |
| Sarah Ellard | Group Legal Director | +44 (0)1794 463420 |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
